人工子宮設施市場 - 全球產業規模、佔有率、趨勢、機會和預測，按技術、應用、最終用戶、地區和競爭細分，2020-2030 年預測

2024 年全球人工子宮設施市場價值為 3.1225 億美元，預計到 2030 年將達到 6.2535 億美元，複合年成長率為 12.27%。全球人工子宮設施市場正處於轉型的邊緣。隨著醫療技術的進步和人們對替代懷孕方法的興趣日益濃厚，人工子宮不再只是科幻小說中的概念，而只是現實。這項突破性的創新有望徹底改變懷孕和分娩方式，為家庭、醫療保健提供者和研究人員提供大量機會。人工子宮，也稱為體外發育室，是一種複製自然子宮條件以支持胎兒在人類體外生長發育的裝置。其目的是提供一個可控的環境，讓早產或有風險的胎兒能夠繼續發育，直到達到可存活階段，從而可能減少與早產相關的併發症。這些設備有助於緩解與傳統懷孕相關的各種醫療和倫理挑戰。

主要市場促進因素

產婦死亡率的降低推動了全球人工子宮設施市場的發展

主要市場挑戰

倫理道德問題

主要市場趨勢

技術進步

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第4章：全球人工子宮設施市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依技術分類（生物反應器、支援設備中的萃取器、其他）
  • 依用途分類（產前護理、新生兒護理）
  • 依最終用戶（超級專科醫院、研究中心、體外受精中心 (IVF)）
  • 按地區
  • 按公司分類（2024）
• 市場地圖
  • 依技術分類
  • 按應用
  • 按最終用戶
  • 按地區

第5章：亞太地區人工子宮設施市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依技術分類
  • 按應用
  • 按最終用戶
  • 按國家
• 亞太地區：國家分析
  • 中國
  • 印度
  • 澳洲
  • 日本
  • 韓國

第 6 章：歐洲人工子宮設施市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 西班牙
  • 義大利
  • 英國

第 7 章：北美人工子宮設施市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 墨西哥
  • 加拿大

第 8 章：南美洲人工子宮設施市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 阿根廷
  • 哥倫比亞

第 9 章：中東和非洲人工子宮設施市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 10 章：市場動態

• 驅動程式
• 挑戰

第 11 章：市場趨勢與發展

• 最新動態
• 產品發布
• 合併與收購

第 12 章：全球人工子宮設施市場：SWOT 分析

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• American University of Beirut (AUB)
• Biotex Inc.
• California Preterm Birth Initiative
• Emmaus Life Sciences, Inc.
• Hebrew University
• Institute of Life Sciences
• Juno Perinatal Healthcare
• Sera Prognostics, Inc.
• Shanghai First Maternity and Infant Hospital
• SomaGenics Inc.

第 15 章：策略建議

第16章調查會社について,免責事項

Global Artificial Womb Facility Market was valued at USD 312.25 Million in 2024 and is expected to reach USD 625.35 Million in the forecast period with a CAGR of 12.27% through 2030. The Global Artificial Womb Facility Market is on the brink of transformation. With advancements in medical technology and a growing interest in alternative methods of gestation, the artificial womb is no longer just a concept from science fiction but a reality. This groundbreaking innovation promises to revolutionize pregnancy and childbirth, offering a multitude of opportunities for families, healthcare providers, and researchers. An artificial womb, also known as an ectogenesis chamber, is a device that replicates the conditions of a natural womb to support the growth and development of a fetus outside of a human body. It aims to provide a controlled environment where a preterm or at-risk fetus can continue to develop until it reaches a viable stage, potentially reducing the complications associated with premature births. These devices can be instrumental in alleviating various medical and ethical challenges associated with traditional pregnancies.

Key Market Drivers

Reduction in Maternal Mortality is Driving the Global Artificial Womb Facility Market

Maternal mortality, a tragic and largely preventable occurrence, has long been a global concern. The World Health Organization (WHO) defines maternal mortality as the death of a woman during pregnancy, childbirth, or within 42 days of termination of pregnancy, irrespective of the duration and site of the pregnancy. While significant progress has been made in reducing maternal mortality rates worldwide, it continues to be a critical issue, particularly in developing countries. As we strive for better healthcare outcomes, one innovative solution is emerging as a potential game-changer: the artificial womb facility. This technology has the potential to significantly reduce maternal mortality and drive the global artificial womb facility market. Maternal mortality is a multifaceted problem that reflects not only the health of women but also the accessibility and quality of healthcare services. The root causes of maternal mortality are varied and complex, including inadequate prenatal care, limited access to healthcare facilities, cultural and social factors, and medical complications during pregnancy and childbirth. According to the WHO, approximately 810 women die every day from preventable causes related to pregnancy and childbirth. This equates to over 295,000 maternal deaths annually. Artificial wombs, often referred to as "ectogenesis," are a groundbreaking technological development in the field of reproductive medicine. These devices aim to provide an environment outside the human body where a developing fetus can thrive. While still in the experimental stage, artificial wombs hold the promise of transforming reproductive healthcare by reducing the risks associated with pregnancy and childbirth. One of the most significant advantages of artificial wombs is the potential to eliminate many of the risks that pregnant women face during the gestational period. Maternal mortality often results from complications related to pregnancy, including preeclampsia, hemorrhage, infections, and obstructed labor. With artificial wombs, the fetus can be safely nurtured outside the mother's body, reducing the risk of these life-threatening complications.

Key Market Challenges

Ethical and Moral Concerns

The ethical and moral concerns surrounding artificial wombs are significant and complex. Questions about when life begins, the potential for misuse, and the creation of a dystopian society where human reproduction is entirely divorced from natural processes have raised red flags among many stakeholders. Striking a balance between technological progress and ethical considerations is a daunting task that the market must confront.

Key Market Trends

Technological Advancements

Technological advancements have played a pivotal role in transforming various aspects of our lives. In recent years, these advancements have extended their reach into the field of healthcare and, specifically, artificial womb technology. The development and adoption of artificial womb facilities are on the rise, driven by increasing technological innovations, which have the potential to revolutionize the way we care for premature babies and address various reproductive health challenges. The progress in biotechnology has led to significant breakthroughs in artificial womb technology. Biocompatible materials, improved incubation systems, and better understanding of fetal development have made it possible to create an environment that closely mimics the mother's womb. Artificial placenta systems have been developed to provide the necessary oxygen and nutrients to the developing fetus, effectively bypassing the need for a natural placenta. This breakthrough technology is a game-changer for the care of premature infants. Technological advancements have allowed for the miniaturization of components, making artificial womb facilities more compact and efficient. This portability can potentially enable care for premature infants in various healthcare settings.

Key Market Players

• American University of Beirut (AUB)
• Biotex Inc.
• California Preterm Birth Initiative
• Emmaus Life Sciences, Inc.
• Hebrew University
• Institute of Life Sciences
• Juno Perinatal Healthcare
• Sera Prognostics, Inc.
• Shanghai First Maternity and Infant Hospital
• SomaGenics Inc.

Report Scope:

In this report, the Global Artificial Womb Facility Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Artificial Womb Facility Market, By Technology:

• Bioreactors
• Extrauter in Support Devices
• Others

Artificial Womb Facility Market, By Application:

• Prenatal Care
• Neonatal Care

Artificial Womb Facility Market, By End user:

• Super Specialty Hospitals
• Research Centers
• In-Vitro Fertilization Centers (IVF)

Artificial Womb Facility Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Artificial Womb Facility Market.

Available Customizations:

Global Artificial Womb Facility market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Artificial Womb Facility Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Technology (Bioreactors, Extrauter in Support Devices, Others)
  • 4.2.2. By Application (Prenatal Care, Neonatal Care)
  • 4.2.3. By End user (Super Specialty Hospitals, Research Centers, In-Vitro Fertilization Centers (IVF))
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Technology
  • 4.3.2. By Application
  • 4.3.3. By End user
  • 4.3.4. By Region

5. Asia Pacific Artificial Womb Facility Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technology
  • 5.2.2. By Application
  • 5.2.3. By End user
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Artificial Womb Facility Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Technology
      • 5.3.1.2.2. By Application
      • 5.3.1.2.3. By End user
  • 5.3.2. India Artificial Womb Facility Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Technology
      • 5.3.2.2.2. By Application
      • 5.3.2.2.3. By End user
  • 5.3.3. Australia Artificial Womb Facility Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Technology
      • 5.3.3.2.2. By Application
      • 5.3.3.2.3. By End user
  • 5.3.4. Japan Artificial Womb Facility Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Technology
      • 5.3.4.2.2. By Application
      • 5.3.4.2.3. By End user
  • 5.3.5. South Korea Artificial Womb Facility Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Technology
      • 5.3.5.2.2. By Application
      • 5.3.5.2.3. By End user

6. Europe Artificial Womb Facility Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technology
  • 6.2.2. By Application
  • 6.2.3. By End user
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Artificial Womb Facility Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technology
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End user
  • 6.3.2. Germany Artificial Womb Facility Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technology
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End user
  • 6.3.3. Spain Artificial Womb Facility Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technology
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End user
  • 6.3.4. Italy Artificial Womb Facility Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Technology
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By End user
  • 6.3.5. United Kingdom Artificial Womb Facility Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Technology
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By End user

7. North America Artificial Womb Facility Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technology
  • 7.2.2. By Application
  • 7.2.3. By End user
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Artificial Womb Facility Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technology
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End user
  • 7.3.2. Mexico Artificial Womb Facility Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technology
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End user
  • 7.3.3. Canada Artificial Womb Facility Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technology
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End user

8. South America Artificial Womb Facility Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technology
  • 8.2.2. By Application
  • 8.2.3. By End user
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Artificial Womb Facility Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technology
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End user
  • 8.3.2. Argentina Artificial Womb Facility Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technology
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End user
  • 8.3.3. Colombia Artificial Womb Facility Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technology
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End user

9. Middle East and Africa Artificial Womb Facility Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technology
  • 9.2.2. By Application
  • 9.2.3. By End user
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Artificial Womb Facility Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technology
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End user
  • 9.3.2. Saudi Arabia Artificial Womb Facility Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technology
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End user
  • 9.3.3. UAE Artificial Womb Facility Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technology
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End user

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Artificial Womb Facility Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. American University of Beirut (AUB)
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Product & Services
  • 14.1.4. Current Capacity Analysis
  • 14.1.5. Financials (In case of listed)
  • 14.1.6. Recent Developments
  • 14.1.7. SWOT Analysis
• 14.2. Biotex Inc.
• 14.3. California Preterm Birth Initiative
• 14.4. Emmaus Life Sciences, Inc.
• 14.5. Hebrew University
• 14.6. Institute of Life Sciences
• 14.7. Juno Perinatal Healthcare
• 14.8. Sera Prognostics, Inc.
• 14.9. Shanghai First Maternity and Infant Hospital
• 14.10.SomaGenics Inc.

15. Strategic Recommendations

16. About Us & Disclaimer